Dexcom Inc’s recent filing unveils that its EVP, Chief Financal Officer Sylvain Jereme M unloaded Company’s shares for reported $0.52 million on Mar 10 ’25. In the deal valued at $73.83 per share,7,000 shares were sold. As a result of this transaction, Sylvain Jereme M now holds 135,482 shares worth roughly $9.52 million.
Then, JEREME SYLVAIN bought 7,000 shares, generating $516,830 in total proceeds.
Before that, Sylvain Jereme M sold 2,090 shares. Dexcom Inc shares valued at $181,650 were divested by the EVP, Chief Financal Officer at a price of $86.91 per share. As a result of the transaction, Sylvain Jereme M now holds 83,526 shares, worth roughly $5.87 million.
Redburn Atlantic upgraded its Dexcom Inc [DXCM] rating to a Buy from a a Neutral in a research note published on February 03, 2025; the price target was increased to $115 from $85. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who increased its forecast for the stock in mid January from “a Neutral” to “an Outperform”. Robert W. Baird also remained covering DXCM and has decreased its forecast on July 26, 2024 with a “Neutral” recommendation from previously “an Outperform” rating. JP Morgan revised its rating on July 26, 2024. It rated DXCM as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of DXCM
On Tuesday, Dexcom Inc [NASDAQ:DXCM] saw its stock fall -0.65% to $70.26. Over the last five days, the stock has lost -14.75%. Dexcom Inc shares have fallen nearly -9.66% since the year began. Nevertheless, the stocks have fallen -47.27% over the past one year. While a 52-week high of $142.00 was reached on 02/18/25, a 52-week low of $62.34 was recorded on 03/11/25. SMA at 50 days reached $84.24, while 200 days put it at $84.77.
Levels Of Support And Resistance For DXCM Stock
The 24-hour chart illustrates a support level at 69.04, which if violated will result in even more drops to 67.81. On the upside, there is a resistance level at 71.47. A further resistance level may holdings at 72.67. The Relative Strength Index (RSI) on the 14-day chart is 23.17, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -10.77, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.57%. Stochastics %K at 4.27% indicates the stock is a buying.
The most recent change occurred on May 30, 2024 when Redburn Atlantic began covering the stock and recommended ‘”a Neutral”‘ rating along with a $130 price target.
